BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18374639)

  • 21. c-Cbl acts as a mediator of Src-induced activation of the PI3K-Akt signal transduction pathway during TRAIL treatment.
    Song JJ; Kim JH; Sun BK; Alcala MA; Bartlett DL; Lee YJ
    Cell Signal; 2010 Mar; 22(3):377-85. PubMed ID: 19861161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cbl-b and PI3K/Akt pathway are differently involved in oxygen-glucose deprivation preconditioning in PC12 cells.
    Zhang W; Yu H; Zou W; Wang YF; Liang XF; Zhang B; Kong JJ; Li P; Zhang DD; Yin L
    Chin Med J (Engl); 2013 Nov; 126(21):4132-8. PubMed ID: 24229686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parathyroid hormone activates phosphoinositide 3-kinase-Akt-Bad cascade in osteoblast-like cells.
    Yamamoto T; Kambe F; Cao X; Lu X; Ishiguro N; Seo H
    Bone; 2007 Feb; 40(2):354-9. PubMed ID: 17046344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raft-partitioning of the ubiquitin ligases Cbl and Nedd4 upon IgE-triggered cell signaling.
    Lafont F; Simons K
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3180-4. PubMed ID: 11248052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily.
    Remacle-Bonnet M; Garrouste F; Baillat G; Andre F; Marvaldi J; Pommier G
    Am J Pathol; 2005 Sep; 167(3):761-73. PubMed ID: 16127155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of Cbl-PI3K interaction modulates the periosteal response to fracture by enhancing osteogenic commitment and differentiation.
    Scanlon V; Walia B; Yu J; Hansen M; Drissi H; Maye P; Sanjay A
    Bone; 2017 Feb; 95():124-135. PubMed ID: 27884787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblast Growth Factor Receptor-2 Contributes to the Basic Fibroblast Growth Factor-Induced Neuronal Differentiation in Canine Bone Marrow Stromal Cells via Phosphoinositide 3-Kinase/Akt Signaling Pathway.
    Nakano R; Edamura K; Nakayama T; Narita T; Okabayashi K; Sugiya H
    PLoS One; 2015; 10(11):e0141581. PubMed ID: 26523832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGFR and PTEN signaling interact during lens development to regulate cell survival.
    Chaffee BR; Hoang TV; Leonard MR; Bruney DG; Wagner BD; Dowd JR; Leone G; Ostrowski MC; Robinson ML
    Dev Biol; 2016 Feb; 410(2):150-163. PubMed ID: 26764128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recruitment of Pyk2 and Cbl to lipid rafts mediates signals important for actin reorganization in growing neurites.
    Haglund K; Ivankovic-Dikic I; Shimokawa N; Kruh GD; Dikic I
    J Cell Sci; 2004 May; 117(Pt 12):2557-68. PubMed ID: 15128873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The PI3K/AKT cell signaling pathway is involved in regulation of osteoporosis.
    Xi JC; Zang HY; Guo LX; Xue HB; Liu XD; Bai YB; Ma YZ
    J Recept Signal Transduct Res; 2015; 35(6):640-5. PubMed ID: 26390889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implication of phosphatidylinositol 3-kinase membrane recruitment in hydrogen peroxide-induced activation of PI3K and Akt.
    Qin S; Chock PB
    Biochemistry; 2003 Mar; 42(10):2995-3003. PubMed ID: 12627965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid rafts as major platforms for signaling regulation in cancer.
    Mollinedo F; Gajate C
    Adv Biol Regul; 2015 Jan; 57():130-46. PubMed ID: 25465296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nef-mediated lipid raft exclusion of UbcH7 inhibits Cbl activity in T cells to positively regulate signaling.
    Simmons A; Gangadharan B; Hodges A; Sharrocks K; Prabhakar S; García A; Dwek R; Zitzmann N; McMichael A
    Immunity; 2005 Dec; 23(6):621-34. PubMed ID: 16356860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abrogation of Cbl-PI3K interaction increases bone formation and osteoblast proliferation.
    Brennan T; Adapala NS; Barbe MF; Yingling V; Sanjay A
    Calcif Tissue Int; 2011 Nov; 89(5):396-410. PubMed ID: 21952831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive feedback loop between PI3K-Akt-mTORC1 signaling and the lipogenic pathway boosts Akt signaling: induction of the lipogenic pathway by a melanoma antigen.
    Yamauchi Y; Furukawa K; Hamamura K; Furukawa K
    Cancer Res; 2011 Jul; 71(14):4989-97. PubMed ID: 21632551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ubiquitin ligase Cbl-b downregulates bone formation through suppression of IGF-I signaling in osteoblasts during denervation.
    Suzue N; Nikawa T; Onishi Y; Yamada C; Hirasaka K; Ogawa T; Furochi H; Kosaka H; Ishidoh K; Gu H; Takeda S; Ishimaru N; Hayashi Y; Yamamoto H; Kishi K; Yasui N
    J Bone Miner Res; 2006 May; 21(5):722-34. PubMed ID: 16734387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parallel phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like growth factor I in osteoblastic cells.
    Grey A; Chen Q; Xu X; Callon K; Cornish J
    Endocrinology; 2003 Nov; 144(11):4886-93. PubMed ID: 12960100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of the PI3K/Akt signaling pathway through P2Y₂ receptors by extracellular ATP is involved in osteoblastic cell proliferation.
    Katz S; Ayala V; Santillán G; Boland R
    Arch Biochem Biophys; 2011 Sep; 513(2):144-52. PubMed ID: 21763267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cbl-b and c-Cbl negatively regulate osteoblast differentiation by enhancing ubiquitination and degradation of Osterix.
    Choi YH; Han Y; Lee SH; Jin YH; Bahn M; Hur KC; Yeo CY; Lee KY
    Bone; 2015 Jun; 75():201-9. PubMed ID: 25744063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Juvenile myelomonocytic leukaemia-associated mutation in Cbl promotes resistance to apoptosis via the Lyn-PI3K/AKT pathway.
    Bunda S; Qin K; Kommaraju K; Heir P; Ohh M
    Oncogene; 2015 Feb; 34(6):789-97. PubMed ID: 24469048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.